NHS
Quarter of cancer patients visit GP three times with no diagnosis
April 25, 2017Manufacturing and Production, Research and Development Cancer, GP, NHS, oncology
A recent study, published in the British Journal of General Practice, has found that 23% of those suffering from cancer …
UK heading towards GP crisis as 40% consider leaving
April 12, 2017Medical Communications, Research and Development GPs, General Practice, Jeremy Hunt, NHS
The University of Exeter has conducted a survey looking into GP morale in the south-west of the UK, and the …
House of Lords slams “short-termism” of NHS in new report
April 6, 2017Medical Communications House of Lords, NHS
A new report from the House of Lords has slammed current and past “short-sighted” governments for failing to provide a …
Women are 77% of NHS workforce but occupy only 41% board positions
March 29, 2017Medical Communications NHS
A new report, entitled Women on NHS board: 50:50 by 2020, found that women occupied only 41% of board positions …
Huge data loss puts NHS privatisation and Health Secretary under pressure
February 28, 2017Manufacturing and Production Jeremy Hunt, NHS, data
It has been revealed that a private company, responsible for delivering NHS data, accidentally stored 708,000 pieces of patient data …
Rise of superbugs in hospitals down to cutting cleaners’ jobs, suggests GMB
February 20, 2017Sales and Marketing GMB, MRSA, NHS, Superbugs
The rising numbers in those exposed to superbugs, such as E.coli and MRSA, is due to the cuts in the …
Artificial Intelligence could take over 250,000 UK roles by 2030
February 8, 2017Medical Communications, Research and Development NHS, artificial intelligence
Ahead of the government’s expected digital strategy publication tomorrow, a new report has been released looking into how AI could …
Insider interview: NICE discusses its planned ‘fast-track’ appraisal process
December 19, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NICE, UK, approval
Jenniffer Prescott, associate director of planning, operations and topic selection, answers questions on NICE’s recent plans for a ‘fast-track’ appraisal …
Actavis UK overcharged NHS with 12,000% price hike, watchdog says
December 16, 2016Medical Communications, Sales and Marketing Actavis, CMA, NHS
Actavis UK has been accused by the Competition and Markets Authority (CMA) of overcharging the NHS by selling its hydrocortisone …
NICE rules Shire’s Onivyde not cost effective
November 17, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NICE, Onivyde, Shire
Shire’s Onivyde has been determined by NICE as not cost effective, in draft guidance, despite adding on average two months …
NHS suppliers investigated over 1000% price hikes
October 26, 2016Research and Development, Sales and Marketing NHS, price hikes
The Competition and Marketing Authority has launched an investigation into a number of drug companies following claims that 32 drugs …
UK Government announces deep cuts to pharmacy funding
October 21, 2016Medical Communications Conservative, NHS, UK, government, pharmacy
The Department Health announced that it wanted to reduce the £2.8 billion a year funding for pharmacies by 7%, leading …
NICE plans new “fast-track” appraisal option
October 14, 2016Medical Communications, Sales and Marketing NHS, NICE
The National Institute for Health and Care Excellence (NICE) has proposed the introduction of a fast-track process which could make …
NICE recommends Forxiga in Triple Therapy for Diabetes
October 7, 2016Medical Communications AstraZeneca, Forxiga, NHS, NICE, diabetes, type 2 diabetes
The news of NICE’s approval of the Forxiga comes in a busy week for AstraZeneca. They have sold three drugs, …
Merck’s Keytruda suffers rejection at hands of NICE
October 5, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSD, Merck, NHS, NICE, keytruda
NICE rejected Merck’s Keytruda, a treatment for advanced non-small-cell lung cancer (NSCLC), on the basis that the drug was not …
Latest content
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
